Minimal manifestation status and prednisone withdrawal in the MGTX trial

Ikjae Lee, Hui Chien Kuo, Inmaculada B. Aban, Gary R. Cutter, Tarrant McPherson, Henry J. Kaminski, Jon Sussman, Philipp Ströbel, Joel Oger, Gabriel Cea, Jeannine M. Heckmann, Amelia Evoli, Wilfred Nix, Emma Ciafaloni, Giovanni Antonini, Rawiphan Witoonpanich, John O. King, Said R. Beydoun, Colin H. Chalk, Alexandru C. BarboiAnthony A. Amato, Aziz I. Shaibani, Bashar Katirji, Bryan R.F. Lecky, Camilla Buckley, Angela Vincent, Elza Dias-Tosta, Hiroaki Yoshikawa, Marcia Waddington-Cruz, Michael T. Pulley, Michael H. Rivner, Anna Kostera-Pruszczyk, Robert M. Pascuzzi, Carlayne E. Jackson, Jan J.G. Verschuuren, Janice M. Massey, John T. Kissel, Lineu C. Werneck, Michael Benatar, Richard J. Barohn, Rup Tandan, Tahseen Mozaffar, Robin Conwit, Greg Minisman, Joshua R. Sonett, Gil I. Wolfe

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Minimal manifestation status and prednisone withdrawal in the MGTX trial'. Together they form a unique fingerprint.

Medicine & Life Sciences